Autosomal dominant polycystic kidney disease: the changing face of clinical management
ACM Ong, O Devuyst, B Knebelmann, G Walz - The Lancet, 2015 - thelancet.com
Autosomal dominant polycystic kidney disease is the most common inherited kidney disease
and accounts for 7–10% of all patients on renal replacement therapy worldwide. Although …
and accounts for 7–10% of all patients on renal replacement therapy worldwide. Although …
Polycystin channel complexes
O Esarte Palomero, M Larmore… - Annual review of …, 2023 - annualreviews.org
Polycystin subunits can form hetero-and homotetrameric ion channels in the membranes of
various compartments of the cell. Homotetrameric polycystin channels are voltage-and …
various compartments of the cell. Homotetrameric polycystin channels are voltage-and …
[HTML][HTML] Drugs in clinical development to treat autosomal dominant polycystic kidney disease
T Bais, RT Gansevoort, E Meijer - Drugs, 2022 - Springer
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive
cyst formation that ultimately leads to kidney failure in most patients. Approximately 10% of …
cyst formation that ultimately leads to kidney failure in most patients. Approximately 10% of …
Right, left and cilia: How asymmetry is established
RB Little, DP Norris - Seminars in Cell & Developmental Biology, 2021 - Elsevier
The initial breaking of left-right (L–R) symmetry in the embryo is controlled by a motile-cilia-
driven leftward fluid flow in the left-right organiser (LRO), resulting in L–R asymmetric gene …
driven leftward fluid flow in the left-right organiser (LRO), resulting in L–R asymmetric gene …
[HTML][HTML] Advances in autosomal dominant polycystic kidney disease: a clinical review
Polycystic kidney disease (PKD) is a multiorgan disorder resulting in fluid-filled cyst
formation in the kidneys and other systems. The replacement of kidney parenchyma with an …
formation in the kidneys and other systems. The replacement of kidney parenchyma with an …
[HTML][HTML] SCF-SKP2 E3 ubiquitin ligase links mTORC1/ER stress/ISR with YAP activation in murine renal cystogenesis
DK Panda, X Bai, Y Zhang… - The Journal of …, 2022 - Am Soc Clin Investig
The Hippo pathway nuclear effector Yes-associated protein (YAP) potentiates the
progression of polycystic kidney disease (PKD) arising from ciliopathies. The mechanisms …
progression of polycystic kidney disease (PKD) arising from ciliopathies. The mechanisms …
[HTML][HTML] Vasopressin–aquaporin-2 pathway: recent advances in understanding water balance disorders
The alteration of water balance and related disorders has emerged as being strictly linked to
the state of activation of the vasopressin–aquaporin-2 (vasopressin–AQP2) pathway. The …
the state of activation of the vasopressin–aquaporin-2 (vasopressin–AQP2) pathway. The …
Spatiotemporal dynamics and heterogeneity of renal lymphatics in mammalian development and cystic kidney disease
DJ Jafree, D Moulding, M Kolatsi-Joannou… - Elife, 2019 - elifesciences.org
Heterogeneity of lymphatic vessels during embryogenesis is critical for organ-specific
lymphatic function. Little is known about lymphatics in the developing kidney, despite their …
lymphatic function. Little is known about lymphatics in the developing kidney, despite their …
[HTML][HTML] Studying kidney diseases using organoid models
The prevalence of chronic kidney disease (CKD) is rapidly increasing over the last few
decades, owing to the global increase in diabetes and cardiovascular diseases. Dialysis …
decades, owing to the global increase in diabetes and cardiovascular diseases. Dialysis …
[HTML][HTML] Molecular pathways involved in injury-repair and ADPKD progression
C Formica, DJM Peters - Cellular Signalling, 2020 - Elsevier
The major hallmark of Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the
formation of many fluid-filled cysts in the kidneys, which ultimately impairs the normal renal …
formation of many fluid-filled cysts in the kidneys, which ultimately impairs the normal renal …